Someone was telling me that if we get FDA approval to to go to P2 and because we have orphan drug status, we will be able to charge patients for the use of PTX-100 meaning we may have an income stream.
Does anyone know the specifics around this?
DW
Ann: September 2023 Quarterly Update and Appendix 4C, page-18
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
4.5¢ |
Change
-0.002(4.26%) |
Mkt cap ! $36.23M | |||
| Open | High | Low | Value | Volume |
| 4.7¢ | 4.7¢ | 4.5¢ | $67.35K | 1.453M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 335381 | 4.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.6¢ | 208695 | 2 |
View Market Depth
| Last trade - 15.48pm 23/07/2025 (20 minute delay) ? |
| PTX (ASX) Chart |